Who is sponsoring NCT03925129?

NCT03925129 is sponsored by Planned Parenthood of Greater New York.

What drugs are being tested in NCT03925129?

Interventions in NCT03925129: high frequency TENS treatment, Sham TENS treatment.

What condition does NCT03925129 study?

NCT03925129 studies Abortion in First Trimester.

Is NCT03925129 still recruiting?

NCT03925129 is currently completed. Last updated 22 April 2021.

Last reviewed 2021-04-22 · How we verify

NCT03925129

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation

Completed NA Last updated 22 April 2021

What this trial tests

NA trial testing high frequency TENS treatment in Abortion in First Trimester in 40 participants. Completed in 13 March 2020.

Timeline

11 June 2019

Primary endpoint
6 March 2020

13 March 2020

Quick facts

Lead sponsor	Planned Parenthood of Greater New York
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	triple
Primary purpose	treatment
Enrollment	40
Start date	11 June 2019
Primary completion	6 March 2020
Estimated completion	13 March 2020
Sites	1 location across United States

Drugs / interventions tested

high frequency TENS treatment
Sham TENS treatment

Conditions studied

Abortion in First Trimester — all drugs for Abortion in First Trimester →

Sponsor

Planned Parenthood of Greater New York — full company profile →

Who can join

18 and older, female only, with Abortion in First Trimester. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a double-blinded, randomized, placebo-controlled trial evaluating the use of High-frequency Transcutaneous Electrical Nerve Stimulation (HfTENS) compared to sham TENS for pain control during medication abortion with mifepristone and misoprostol through 70 days' gestation.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Pain management for medical abortion before 14 weeks' gestation.
Reynolds-Wright JJ, Woldetsadik MA, Morroni C, Cameron S. · · 2022 · cited 7× · PMID 35553047 · DOI 10.1002/14651858.cd013525.pub2
Transcutaneous Electrical Nerve Stimulation to Reduce Pain With Medication Abortion: A Randomized Controlled Trial.
Goldman AR, Porsch L, Hintermeister A, Dragoman M. · · 2021 · cited 6× · PMID 33278292 · DOI 10.1097/aog.0000000000004208

Verify or expand the search:

Other recruiting trials for Abortion in First Trimester

Currently open trials in the same condition.

NCT06787274 — Research on Equity in Abortion Care by TeleHealth · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03925129 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Planned Parenthood of Greater New York
Last refreshed: 22 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03925129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing